Weight Management – Tirzepatide

Tirzepatide may be prescribed by a licensed healthcare provider as part of a weight management plan for adults who meet clinical eligibility criteria. Treatment decisions are based on individual health information and provider review. Access to medication is coordinated through EPIC Health’s pharmacy partner when appropriate.

Common Reasons for Use

• Body mass index (BMI) of 30 or higher
• BMI of 27 or higher with a weight-related condition
• Difficulty achieving weight management goals through diet and physical activity alone

Possible Benefits

• Supports participation in a provider-guided weight management plan
• May be included as part of a broader health and lifestyle approach
• Allows for individualized care based on provider evaluation

How It’s Used

• Prescribed as a once-weekly subcutaneous injection
• Dosing is adjusted gradually according to provider direction
• Used alongside nutrition and physical activity recommendations

Important Information

Compounded tirzepatide is not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality. All treatment decisions, risk discussions, and eligibility determinations are made directly between patients and licensed healthcare providers as part of the clinical review process.